BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9834070)

  • 1. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
    Li X; Carter RH
    J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
    Li X; Sandoval D; Freeberg L; Carter RH
    J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19 signal transduction in normal human B cells: linkage to downstream pathways requires phosphatidylinositol 3-kinase, protein kinase C and Ca2+.
    Li X; Carter RH
    Eur J Immunol; 2000 Jun; 30(6):1576-86. PubMed ID: 10898493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities.
    Kawauchi K; Lazarus AH; Sanghera JS; Man GL; Pelech SL; Delovitch TL
    Mol Immunol; 1996 Feb; 33(3):287-96. PubMed ID: 8649450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
    Tooze RM; Doody GM; Fearon DT
    Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
    Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
    Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line.
    Kumar G; Wang S; Gupta S; Nel A
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):215-23. PubMed ID: 7717978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
    Whisler RL; Newhouse YG; Bagenstose SE
    Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Geppert TD; Whitehurst CE; Thompson P; Beutler B
    Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes.
    Tordai A; Franklin RA; Patel H; Gardner AM; Johnson GL; Gelfand EW
    J Biol Chem; 1994 Mar; 269(10):7538-43. PubMed ID: 8125975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src.
    Zimmermann S; Rommel C; Ziogas A; Lovric J; Moelling K; Radziwill G
    Oncogene; 1997 Sep; 15(13):1503-11. PubMed ID: 9380402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc.
    Miranti CK; Ohno S; Brugge JS
    J Biol Chem; 1999 Apr; 274(15):10571-81. PubMed ID: 10187852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
    Piatelli MJ; Doughty C; Chiles TC
    J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.